13F Pro13F Pro

Blue Water Life Science Advisors, LP

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1789778
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare96.2%$152.6M
  • Technology3.9%$6.1M

AUM History

13fpro.ai/research/fund/blue-water-life-science-advisors-lp-1789778

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/blue-water-life-science-advisors-lp-1789778

Blue Water Life Science Advisors, LP 13F holdings — Q2 2026

$158.8M portfolio (+27.3% QoQ) · 9 holdings · Q2 2026 13F · top 10 are 100% of the stock portfolio

What changed in Q2 2026

Against the previous quarter's 13F: 0 new, 3 added to, 4 trimmed, 1 sold out. Share-count changes; largest moves by dollar size first.

New positions (0)

No new positions this quarter.

Added to (3)

  • CDNA$CDNACareDx, Inc.+27%

    now $33.9M · held 9 qtrs, 2 adds in a row

  • BLLN$BLLNBillionToOne, Inc.+250%

    now $8.4M · held 2 qtrs, 2 adds in a row

  • QTRX$QTRXQuanterix Corp+62%

    now $15.0M · held 10+ qtrs, 3 adds in a row

Trimmed (4)

  • GH$GHGuardant Health, Inc.-53%

    now $17.2M · held 10+ qtrs, 5 trims in a row

  • TXG$TXG10x Genomics, Inc.-41%

    now $24.6M · held 2 qtrs

  • TEM$TEMTempus AI, Inc.-33%

    now $6.1M · held 4 qtrs

  • NTRA$NTRANatera, Inc.-23%

    now $9.4M · held 10+ qtrs, 2 trims in a row

Sold out (1)

  • TWST$TWSTTwist Bioscience Corpwas $13.1M

    held 2 qtrs

Firm AUM (Form ADV): $192.6M as of 2025-12-31 · SEC IAPD

Holdings by quarter

Every 13F Blue Water Life Science Advisors, LP has filed, 22 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Blue Water Life Science Advisors?

Q2 2026 13F filed with the SEC on Aug 14, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of Blue Water Life Science Advisors's top 20 holdings: 42/100 (our AI quality score, weighted by position size; 9 of the 20 are scored)

Top 10 since filing

+24.5%

Value-weighted move of the 10 largest stock positions

Turnover

13%

Last quarter; 52% over the last 4

Top 10 weight

100%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

79%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Blue Water Life Science Advisors, LP disclosed 9 positions worth $158.8M in its Form 13F-HR for Q2 2026, led by $CDNA (CareDx, Inc.) at 21.4% of the equity portfolio, followed by $TXG and $PSNL. During the quarter the fund opened 0 new positions and exited 1 and a full exit from $TWST. The portfolio is most concentrated in Healthcare (96.2% of disclosed assets). All figures are sourced directly from Blue Water Life Science Advisors, LP’s Form 13F-HR filing with the SEC under CIK 1789778.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Blue Water Life Science Advisors, LP

13F Pro is an AI hedge fund tracker and stock research platform. For Blue Water Life Science Advisors, LP (SEC CIK: 1789778), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Blue Water Life Science Advisors, LP's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.